Genentech, OSI Pharmaceuticals Agree To Pay $67M Over Cancer Drug Tarceva Allegations
Genentech and OSI Pharmaceuticals agreed to pay $67 million to settle allegations they misled doctors about the effectiveness of the cancer drug, Tarceva.between January 2006 and December 2011.